18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
Klaus Kopka,Martina Benesova,Jens Cardinale,Matthias Eder,Martin Schäfer,Ulrike Bauder-Wüst,Uwe Haberkorn,Michael Eisenhut
申请号：
US15463059
公开号：
US10016519B2
申请日:
2017.03.20
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer.
